Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
In an experiment the HYPOTHESIS is tested. The hypothesis is the assumption, that you make about something. Example would be, you believe (hypothesize) that the baking soda will react faster in vinegar than in water. You then test it out (or preform and experiment) to see if your hypothesis is correct or wrong.
The answer is a
Hope this helped
Recombination or crossing over occurs during prophase i. homologue chromosomes- 1 inherited from each parent pair along their lengths gene by gene. Independent Assortment is the process where the chromosomes move randomly to seperate poles during meiosis
